Cargando…

Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice

Bacteremic Streptococcus pneumoniae pneumonia is one of the most severe forms of invasive pneumococcal disease (IPD) and with particularly high case-fatality rates among the elderly and individuals with comorbidities, exacerbated by rising antibiotic resistance and time to initiation of therapy. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogunniyi, Abiodun D., Nguyen, Hang Thi, Hansford, Karl A., Cooper, Matthew A., Trott, Darren J., Blaskovich, Mark A. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580989/ https://www.ncbi.nlm.nih.gov/pubmed/37606382 http://dx.doi.org/10.1128/spectrum.04459-22

Ejemplares similares

In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
por: Cho, Hye-Kyung, et al.
Publicado: (2021)

Epididymitis associated with bacteremic pneumococcal pneumonia
por: Berlinrut, Ilan, et al.
Publicado: (2021)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

Empyema and bacteremic pneumococcal pneumonia in children under five years of age,
por: Cardoso, Maria Regina Alves, et al.
Publicado: (2014)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
por: Khasawneh, Faisal A, et al.
Publicado: (2014)

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
por: Benfield, Thomas, et al.
Publicado: (2013)

VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells
por: Vimberg, Vladimir, et al.
Publicado: (2020)

A Leukocyte Score to Improve Clinical Outcome Predictions in Bacteremic Pneumococcal Pneumonia in Adults
por: Blot, Mathieu, et al.
Publicado: (2014)

More than Meets the Eye: Bacteremic Pneumococcal Pneumonia as the Initial Presentation of Multiple Myeloma
por: Jautz, Jonas, et al.
Publicado: (2021)

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

1460. Community-Acquired Bacteremic Pneumonia in Post-pneumococcal Vaccination Era in a Pediatric Hospital
por: Gentile, Angela, et al.
Publicado: (2018)

Moraxella catarrhalis bacteremic pneumonia
por: Anezaki, Hiroki, et al.
Publicado: (2020)

Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A
por: Poshvina, Darya V., et al.
Publicado: (2022)

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study
por: Li, Fuxing, et al.
Publicado: (2023)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based study
por: Beatty, Jessica A., et al.
Publicado: (2016)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
por: Morrisette, Taylor, et al.
Publicado: (2019)

Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)

327. Comparison of Clinical Outcome, Causative Serotypes, and Antimicrobial Susceptibilities Between Pneumococcal Meningitis and Pneumococcal Bacteremic Pneumonia in Adult Patients in the Republic of Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2018)

Acetylsalicylic acid use is associated with improved survival in bacteremic pneumococcal pneumonia: A long‐term nationwide study
por: Rögnvaldsson, Kristján G., et al.
Publicado: (2022)

The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009–2017
por: Chowers, Michal, et al.
Publicado: (2022)

1475. Impact of a Routine Infant PCV Program on the Serotype Distribution of Episodes of Invasive Pneumococcal Disease (IPD) and Non-bacteremic Pneumococcal Pneumonia in Adults
por: McGeer, Allison
Publicado: (2020)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
por: Ruiz, Luis A., et al.
Publicado: (2017)

A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
por: Guillamet, Cristina Vazquez, et al.
Publicado: (2016)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Bacteremic nosocomial pneumonia cases from the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2010)

Developments in Glycopeptide Antibiotics
por: Blaskovich, Mark A. T., et al.
Publicado: (2018)

1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020)

Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
por: Chen, I-Ren, et al.
Publicado: (2022)

Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile
por: Fica, Alberto, et al.
Publicado: (2013)

Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study
por: Tan, Yunfang, et al.
Publicado: (2017)

Tsukamurella tyrosinosolvens - An unusual case report of bacteremic pneumonia after lung transplantation
por: Ménard, Armelle, et al.
Publicado: (2009)

Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
por: Cheng, Mu, et al.
Publicado: (2014)

Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections
por: Nguyen, Hang Thi, et al.
Publicado: (2021)

Characterization of Staphylococcal Cassette Chromosome mec Elements from Methicillin-Resistant Staphylococcus pseudintermedius Infections in Australian Animals
por: Worthing, Kate A., et al.
Publicado: (2018)

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome
por: Negash, Abel Abera, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g73r4rms6d54745c3m9s99t8n6